Deep Science Ventures Fund III

Deep Science Ventures

Status

ACTIVE

Global HQ

London, United Kingdom

Countries of investment

United Kingdom
United States
Netherlands
Germany
France
Australia
Canada
Ireland

Investment stages

Pre-Seed
Seed
Series A

Industries

Climate
Pharma
Agriculture
Computing
Energy
DeepTech
Biotech
Advanced Materials
Life Sciences

About
Deep Science Ventures is a London-based venture capital firm focused on venture-building science companies from thesis. Their focus spans climate, pharma, agriculture, computing, and energy across United Kingdom, United States, Netherlands, Germany, France, Australia, Canada, and Ireland. The firm supports science venture founders from pre-seed through Series A stages.

Min check size: $100K
Max check size: $500K
Fund size: Unlock
NPS: Unlock

Investment Thesis

Deep Science Ventures is a pre-seed to Series A stage venture capital firm deploying capital across climate, pharma, agriculture, computing, and energy sectors. They invest in venture-built science ventures created through their proprietary founder-development program, combining PhD scientists with commercial operators to build companies from thesis. The firm differentiates itself as a venture-builder VC creating category-defining science companies through their unique founder-in-residence model rather than sourcing existing startups.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Founded in 2016 by Mark Hammond (Founder and CEO, former research scientist) and Dominic Falcao (Co-founder and Director). Team of 20+ scientists, operators, and investment professionals based in London. Operates a unique venture-building model where PhD scientists (Founders-in-Residence) are paired with commercial operators to build companies from thesis rather than sourcing existing startups. Manages multiple funds with £100M+ AUM. Backed by Innovate UK, EPSRC, family offices, and institutional investors. Portfolio includes SEA Fisheries Innovation, Photocentric, Deep Branch Biotech, Cusp Bio, Nium (climate), Farosonics, and 60+ venture-built companies across climate, pharma, agriculture, computing, and energy sectors. The firm has pioneered thesis-driven science venture building as a category, working with universities and research institutions globally to commercialize breakthrough science through purpose-built ventures.